Clinical Trial Results: Ph1 T-Regulatory Cells in Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating regulatory T cells in amyotrophic lateral sclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 1 | Status: COMPLETED | Results posted: 2026-06-17